About
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Key Metrics
as of Sep 2026Quarterly Results
Rs. Crores Β· hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 186.00 | 173.00 | 153.00 | 150.00 | 148.00 | 150.00 | 122.00 | 3.00 | 30.00 | 517.00 | 276.00 | 270.00 | 299.00 |
| Expenses | 153.00 | 152.00 | 144.00 | 148.00 | 145.00 | 158.00 | 122.00 | 15.00 | 35.00 | 430.00 | 222.00 | 207.00 | 239.00 |
| Operating Profit | 33.00 | 20.00 | 9.00 | 2.00 | 3.00 | -9.00 | -1.00 | -12.00 | -5.00 | 87.00 | 54.00 | 63.00 | 60.00 |
| OPM % | 18.00 | 12.00 | 6.00 | 1.40 | 2.10 | -6.00 | -0.80 | -443.00 | -15.00 | 17.00 | 20.00 | 23.00 | 20.00 |
| Other Income | 7.00 | -3.00 | 18.00 | 18.00 | 15.00 | 216.00 | 16.00 | 13.00 | 11.00 | 458.00 | 7.00 | 7.00 | 6.00 |
| Depreciation | 8.00 | 8.00 | 9.00 | 7.00 | 7.00 | 7.00 | 6.00 | 0.00 | 0.00 | 20.00 | 14.00 | 13.00 | 14.00 |
| Interest | 1.00 | -2.00 | 1.00 | 2.00 | 1.00 | -27.00 | 10.00 | 0.00 | 0.00 | 3.00 | 21.00 | 21.00 | 20.00 |
| Profit before tax | 32.00 | 12.00 | 18.00 | 11.00 | 10.00 | 226.00 | -1.00 | 0.00 | 6.00 | 523.00 | 27.00 | 36.00 | 31.00 |
| Tax % | 25.00 | -27.00 | 39.00 | 21.00 | 17.00 | 4.00 | 0.00 | 0.00 | 0.00 | 6.00 | 19.00 | 17.00 | 45.00 |
| Net Profit | 24.00 | 15.00 | 11.00 | 9.00 | 8.00 | 218.00 | -1.00 | 0.00 | 6.00 | 491.00 | 22.00 | 30.00 | 17.00 |
| EPS in Rs | 2.81 | 1.72 | 1.32 | 1.07 | 1.34 | 35.98 | -0.15 | 0.05 | 1.05 | 83.05 | 3.66 | 5.09 | 2.89 |
Profit & Loss
Annual Β· Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 636.00 | 550.00 | 1,673.00 | 1,152.00 | 988.00 | 857.00 | 752.00 | 724.00 | 731.00 | 694.00 | 639.00 | 646.00 |
| Expenses | 590.00 | 563.00 | 1,371.00 | 930.00 | 788.00 | 676.00 | 610.00 | 599.00 | 604.00 | 589.00 | 532.00 | 557.00 |
| Operating Profit | 46.00 | -13.00 | 302.00 | 222.00 | 200.00 | 180.00 | 142.00 | 125.00 | 127.00 | 105.00 | 107.00 | 89.00 |
| OPM % | 7.00 | -2.40 | 18.00 | 19.00 | 20.00 | 21.00 | 19.00 | 17.00 | 17.00 | 15.00 | 17.00 | 14.00 |
| Other Income | 36.00 | 304.00 | 476.00 | 7.00 | 34.00 | 23.00 | 36.00 | 130.00 | 16.00 | 15.00 | 1.00 | -31.00 |
| Interest | 1.00 | 3.00 | 104.00 | 92.00 | 96.00 | 100.00 | 107.00 | 92.00 | 28.00 | 88.00 | 106.00 | 117.00 |
| Depreciation | 31.00 | 24.00 | 80.00 | 57.00 | 131.00 | 87.00 | 90.00 | 104.00 | 87.00 | 88.00 | 85.00 | 84.00 |
| Profit before tax | 50.00 | 264.00 | 594.00 | 79.00 | 8.00 | 16.00 | -20.00 | 59.00 | 29.00 | -56.00 | -83.00 | -143.00 |
| Tax % | 15.00 | 3.00 | 10.00 | 46.00 | 171.00 | 127.00 | 6.00 | 35.00 | 38.00 | -29.00 | -29.00 | -17.00 |
| Net Profit | 43.00 | 256.00 | 536.00 | 42.00 | -6.00 | -4.00 | -21.00 | 39.00 | 18.00 | -40.00 | -59.00 | -119.00 |
| EPS in Rs | 4.90 | 42.25 | 90.74 | 7.19 | -0.97 | -0.74 | -3.52 | 8.11 | 3.89 | -8.88 | -14.37 | -29.09 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 87.00 | 69.00 | 67.00 | 60.00 | 60.00 | 60.00 | 60.00 | 48.00 | 46.00 | 45.00 | 42.00 | 42.00 |
| Reserves | 1,284.00 | 1,095.00 | 731.00 | 616.00 | 573.00 | 579.00 | 585.00 | 542.00 | 497.00 | 480.00 | 473.00 | 551.00 |
| Borrowings | 20.00 | 37.00 | 214.00 | 854.00 | 944.00 | 996.00 | 1,031.00 | 1,148.00 | 1,083.00 | 1,242.00 | 1,457.00 | 1,413.00 |
| Other Liabilities | 263.00 | 221.00 | 396.00 | 259.00 | 226.00 | 182.00 | 184.00 | 174.00 | 371.00 | 353.00 | 238.00 | 233.00 |
| Total Liabilities | 1,654.00 | 1,422.00 | 1,408.00 | 1,788.00 | 1,803.00 | 1,817.00 | 1,860.00 | 1,913.00 | 1,997.00 | 2,121.00 | 2,210.00 | 2,238.00 |
| Fixed Assets | 306.00 | 273.00 | 192.00 | 587.00 | 630.00 | 752.00 | 843.00 | 913.00 | 934.00 | 1,042.00 | 1,095.00 | 1,114.00 |
| CWIP | 10.00 | 0.00 | 51.00 | 8.00 | 10.00 | 19.00 | 11.00 | 20.00 | 69.00 | 70.00 | 82.00 | 115.00 |
| Investments | 330.00 | 269.00 | 167.00 | 85.00 | 111.00 | 55.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 |
| Other Assets | 1,008.00 | 880.00 | 998.00 | 1,108.00 | 1,052.00 | 991.00 | 979.00 | 953.00 | 968.00 | 982.00 | 1,007.00 | 983.00 |
| Total Assets | 1,654.00 | 1,422.00 | 1,408.00 | 1,788.00 | 1,803.00 | 1,817.00 | 1,860.00 | 1,913.00 | 1,997.00 | 2,121.00 | 2,210.00 | 2,238.00 |
Cash Flows
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -40.00 | -39.00 | -166.00 | 183.00 | 136.00 | 135.00 | 123.00 | -75.00 | 71.00 | 93.00 | 80.00 | 100.00 |
| Cash from Investing Activity | -100.00 | -110.00 | -28.00 | -14.00 | 3.00 | -10.00 | -10.00 | -2.00 | -17.00 | -31.00 | -30.00 | -37.00 |
| Cash from Financing Activity | 145.00 | 74.00 | 658.00 | -168.00 | -140.00 | -124.00 | -133.00 | 100.00 | -62.00 | -69.00 | -48.00 | -64.00 |
| Net Cash Flow | 5.00 | -75.00 | 464.00 | 1.00 | -1.00 | 1.00 | -20.00 | 23.00 | -8.00 | -7.00 | 3.00 | 0.00 |
| Free Cash Flow | -127.00 | -65.00 | -229.00 | 170.00 | 123.00 | 131.00 | 112.00 | -90.00 | 50.00 | 61.00 | 50.00 | 60.00 |
| CFO/OP % | -72.00 | 303.00 | -55.00 | 82.00 | 68.00 | 75.00 | 87.00 | -60.00 | 56.00 | 88.00 | 75.00 | 112.00 |
Ratios
Annual Β· Days / % β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 108.00 | 106.00 | 56.00 | 149.00 | 158.00 | 171.00 | 187.00 | 168.00 | 191.00 | 179.00 | 205.00 | 212.00 |
| Inventory Days | 184.00 | 137.00 | 28.00 | 253.00 | 303.00 | 304.00 | 330.00 | 302.00 | 305.00 | 317.00 | 377.00 | 319.00 |
| Days Payable | 185.00 | 141.00 | 114.00 | 114.00 | 120.00 | 106.00 | 122.00 | 110.00 | 112.00 | 88.00 | 137.00 | 119.00 |
| Cash Conversion Cycle | 107.00 | 102.00 | -30.00 | 287.00 | 342.00 | 368.00 | 395.00 | 359.00 | 384.00 | 409.00 | 445.00 | 412.00 |
| Working Capital Days | 120.00 | 83.00 | -7.00 | 226.00 | 249.00 | 243.00 | 256.00 | 225.00 | -59.00 | -106.00 | -35.00 | 32.00 |
| ROCE % | 5.00 | 1.00 | 21.00 | 13.00 | 7.00 | 7.00 | 5.00 | 4.00 | 3.00 | 2.00 | 2.00 | 1.00 |
Corporate Actions
20 records| Action | Ex Date | Record Date | Ratio | Amount (βΉ) | Notes |
|---|---|---|---|---|---|
| Other | 24 Sep 2024 | β | β | β | Annual General Meeting |
| Other | 22 Sep 2023 | β | β | β | Annual General Meeting |
| Other | 22 Sep 2022 | β | β | β | Annual General Meeting |
| Other | 23 Sep 2021 | β | β | β | Annual General Meeting |
| Other | 23 Sep 2020 | β | β | β | Annual General Meeting |
| Other | 24 Sep 2019 | β | β | β | Annual General Meeting |
| Other | 19 Sep 2018 | β | β | β | Annual General Meeting |
| Other | 14 Sep 2017 | β | β | β | Annual General Meeting |
| Other | 20 Sep 2016 | β | β | β | Annual General Meeting |
| Other | 18 Sep 2015 | β | β | β | Annual General Meeting |
| Other | 18 Sep 2014 | β | β | β | Annual General Meeting |
| Other | 24 Sep 2013 | β | β | β | Annual General Meeting |
| Other | 21 Sep 2012 | β | β | β | Annual General Meeting |
| Dividend | 20 Sep 2011 | β | β | 1.00 | |
| Dividend | 16 Sep 2010 | β | β | 1.00 | |
| Dividend | 17 Sep 2009 | β | β | 1.00 | |
| Dividend | 18 Sep 2008 | β | β | 1.00 | |
| Dividend | 21 Sep 2007 | β | β | 1.00 | |
| Dividend | 22 Sep 2006 | β | β | 1.50 | |
| Dividend | 22 Sep 2005 | β | β | 1.50 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results β Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update29 Mar 2024 from care
-
Rating update7 Dec 2023 from care
-
Rating update15 Sep 2023 from care
-
Rating update8 Nov 2022 from care
-
Rating update23 Dec 2021 from care
-
Rating update10 Aug 2021 from care